Jun11119R for COVID-19

 Jun11119R has been reported as potentially beneficial for COVID-19 in the following study.
COVID-19 involves the interplay of 350+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 10,000+ potential treatments. c19early.org analyzes 200+ treatments. We have not reviewed Jun11119R in detail.
Tan et al., Exploring diverse reactive warheads for the design of SARS-CoV-2 main protease inhibitors, European Journal of Medicinal Chemistry, doi:10.1016/j.ejmech.2023.115667